Literature DB >> 19033588

Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease.

Mary A Whooley1, Peter de Jonge, Eric Vittinghoff, Christian Otte, Rudolf Moos, Robert M Carney, Sadia Ali, Sunaina Dowray, Beeya Na, Mitchell D Feldman, Nelson B Schiller, Warren S Browner.   

Abstract

CONTEXT: Depressive symptoms predict adverse cardiovascular outcomes in patients with coronary heart disease, but the mechanisms responsible for this association are unknown.
OBJECTIVE: To determine why depressive symptoms are associated with an increased risk of cardiovascular events. DESIGN AND PARTICIPANTS: The Heart and Soul Study is a prospective cohort study of 1017 outpatients with stable coronary heart disease followed up for a mean (SD) of 4.8 (1.4) years.
SETTING: Participants were recruited between September 11, 2000, and December 20, 2002, from 12 outpatient clinics in the San Francisco Bay Area and were followed up to January 12, 2008. MAIN OUTCOME MEASURES: Baseline depressive symptoms were assessed using the Patient Health Questionnaire (PHQ). We used proportional hazards models to evaluate the extent to which the association of depressive symptoms with subsequent cardiovascular events (heart failure, myocardial infarction, stroke, transient ischemic attack, or death) was explained by baseline disease severity and potential biological or behavioral mediators.
RESULTS: A total of 341 cardiovascular events occurred during 4876 person-years of follow-up. The age-adjusted annual rate of cardiovascular events was 10.0% among the 199 participants with depressive symptoms (PHQ score > or = 10) and 6.7% among the 818 participants without depressive symptoms (hazard ratio [HR], 1.50; 95% confidence interval, [CI], 1.16-1.95; P = .002). After adjustment for comorbid conditions and disease severity, depressive symptoms were associated with a 31% higher rate of cardiovascular events (HR, 1.31; 95% CI, 1.00-1.71; P = .04). Additional adjustment for potential biological mediators attenuated this association (HR, 1.24; 95% CI, 0.94-1.63; P = .12). After further adjustment for potential behavioral mediators, including physical inactivity, there was no significant association (HR, 1.05; 95% CI, 0.79-1.40; P = .75).
CONCLUSION: In this sample of outpatients with coronary heart disease, the association between depressive symptoms and adverse cardiovascular events was largely explained by behavioral factors, particularly physical inactivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19033588      PMCID: PMC2677371          DOI: 10.1001/jama.2008.711

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  77 in total

1.  National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

Authors:  L N Robins; J E Helzer; J Croughan; K S Ratcliff
Journal:  Arch Gen Psychiatry       Date:  1981-04

2.  Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents.

Authors:  H W Cohen; G Gibson; M H Alderman
Journal:  Am J Med       Date:  2000-01       Impact factor: 4.965

3.  Construct validity of self-reported historical physical activity.

Authors:  Heather R Bowles; Shannon J FitzGerald; James R Morrow; Allen W Jackson; Steven N Blair
Journal:  Am J Epidemiol       Date:  2004-08-01       Impact factor: 4.897

4.  Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study.

Authors:  Christian Otte; Charles R Marmar; Sharon S Pipkin; Rudolf Moos; Warren S Browner; Mary A Whooley
Journal:  Biol Psychiatry       Date:  2004-08-15       Impact factor: 13.382

5.  Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes.

Authors:  Nancy Frasure-Smith; François Lespérance; Pierre Julien
Journal:  Biol Psychiatry       Date:  2004-05-01       Impact factor: 13.382

6.  Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study.

Authors:  Robert M Carney; James A Blumenthal; Kenneth E Freedland; Marston Youngblood; Richard C Veith; Matthew M Burg; Carol Cornell; Patrice G Saab; Peter G Kaufmann; Susan M Czajkowski; Allan S Jaffe
Journal:  Psychosom Med       Date:  2004 Jul-Aug       Impact factor: 4.312

7.  Concurrent and predictive validity of a self-reported measure of medication adherence.

Authors:  D E Morisky; L W Green; D M Levine
Journal:  Med Care       Date:  1986-01       Impact factor: 2.983

8.  The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease.

Authors:  S G Haynes; M Feinleib; W B Kannel
Journal:  Am J Epidemiol       Date:  1980-01       Impact factor: 4.897

Review 9.  Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment.

Authors:  Heather S Lett; James A Blumenthal; Michael A Babyak; Andrew Sherwood; Timothy Strauman; Clive Robins; Mark F Newman
Journal:  Psychosom Med       Date:  2004 May-Jun       Impact factor: 4.312

10.  Relation between depressive symptoms and treadmill exercise capacity in the Heart and Soul Study.

Authors:  Bernice Ruo; John S Rumsfeld; Sharon Pipkin; Mary A Whooley
Journal:  Am J Cardiol       Date:  2004-07-01       Impact factor: 2.778

View more
  284 in total

1.  Association of Psychosocial Symptoms, Blood Pressure, and Menopausal Status in African-American Women.

Authors:  Carolyn H Still; Sadia Tahir; Hossein N Yarandi; Mona Hassan; Faye A Gary
Journal:  West J Nurs Res       Date:  2020-06-26       Impact factor: 1.967

2.  Directionality of the relationship between depressive symptom dimensions and C-reactive protein in patients with acute coronary syndromes.

Authors:  Jonathan A Shaffer; Donald Edmondson; William F Chaplin; Joseph E Schwartz; Daichi Shimbo; Matthew M Burg; Nina Rieckmann; Karina W Davidson
Journal:  Psychosom Med       Date:  2011-06-02       Impact factor: 4.312

Review 3.  Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review.

Authors:  An Pan; Qi Sun; Olivia I Okereke; Kathryn M Rexrode; Frank B Hu
Journal:  JAMA       Date:  2011-09-21       Impact factor: 56.272

4.  Purpose in life and reduced risk of myocardial infarction among older U.S. adults with coronary heart disease: a two-year follow-up.

Authors:  Eric S Kim; Jennifer K Sun; Nansook Park; Laura D Kubzansky; Christopher Peterson
Journal:  J Behav Med       Date:  2012-02-23

Review 5.  Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma.

Authors:  Gilberto Paz-Filho; Julio Licinio; Ma-Li Wong
Journal:  Braz J Psychiatry       Date:  2010-06       Impact factor: 2.697

6.  Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.

Authors:  Ruth Dubin; Yongmei Li; Joachim H Ix; Michael G Shlipak; Mary Whooley; Carmen A Peralta
Journal:  Am Heart J       Date:  2012-02       Impact factor: 4.749

7.  The impact of medication nonadherence on the relationship between mortality risk and depression in heart failure.

Authors:  Emily C Gathright; Mary A Dolansky; John Gunstad; Joseph D Redle; Richard A Josephson; Shirley M Moore; Joel W Hughes
Journal:  Health Psychol       Date:  2017-07-20       Impact factor: 4.267

8.  PURLs: SSRIs for depression/heart failure patients? Not so fast.

Authors:  Jason Ricco; Janice Benson; Shailendra Prasad
Journal:  J Fam Pract       Date:  2017-09       Impact factor: 0.493

Review 9.  [Depression and neurological diseases].

Authors:  D Piber; K Hinkelmann; S M Gold; C Heesen; C Spitzer; M Endres; C Otte
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

Review 10.  State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease.

Authors:  Beth E Cohen; Donald Edmondson; Ian M Kronish
Journal:  Am J Hypertens       Date:  2015-04-24       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.